Antithymocyte globulin induction therapy adjusted for immunologic risk after heart transplantation

Transplantation Proceedings

Volumn 45, Issue 6, 2013, Pages 2393-2398

  Czer, L S C ^a   Phan, A ^a   Ruzza, A ^a   Rafiei, M ^a   Setareh Shenas, S ^a   Caceres, M ^a   Awad, M ^a   Soliman, C ^a   Mirocha, J ^a   De Robertis, M ^a   Kass, R M ^a   Trento, A ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AZATHIOPRINE; CREATININE; CYCLOSPORIN; GANCICLOVIR; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PANEL REACTIVE ANTIBODY; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR;

ACUTE GRAFT REJECTION; ADULT; AFRICAN AMERICAN; ANTIBODY MEDIATED REJECTION; ARTICLE; CARDIAC GRAFT REJECTION; CYTOMEGALOVIRUS INFECTION; DISEASE FREE INTERVAL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEMALE; GASTROINTESTINAL SYMPTOM; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HIGH RISK POPULATION; HOSPITAL DISCHARGE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTIPARA; PNEUMONIA; PRIORITY JOURNAL; SURGICAL RISK; TREATMENT DURATION;

ADMINISTRATION, INTRAVENOUS; ADULT; AGED; ANTILYMPHOCYTE SERUM; BIOPSY; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; LOS ANGELES; MALE; MIDDLE AGED; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84882250057     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2013.02.114     Document Type: Article

References (34)

1. X. Preville, M. Flacher, and B. LeMauff Mechanisms involved in antithymocyte globulin immunosuppressive activity in a nonhuman primate model Transplantation 71 3 2001 460 468
2. M.R. Costanzo, A. Dipchand, and R. Starling The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients J Heart Lung Transplant 29 8 2010 914 956
3. J. Stehlik, L.B. Edwards, and A.Y. Kucheryavaya The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Heart Transplant Report-2011 J Heart Lung Transplant 30 10 2011 1078 1094
4. C. Blanche, L.S. Czer, M. Valenza, and A. Trento Alternative technique for orthotopic heart transplantation Ann Thorac Surg 57 3 1994 765 767
5. C. Blanche, M. Valenza, I. Aleksic, L.S. Czer, and A. Trento Technical considerations of a new technique for orthotopic heart transplantation. Total excision of recipient's atria with bicaval and pulmonary venous anastomoses J Cardiovasc Surg 35 4 1994 283 287
6. C. Blanche, M. Valenza, and L.S. Czer Orthotopic heart transplantation with bicaval and pulmonary venous anastomoses Ann Thorac Surg 58 5 1994 1505 1509
7. L.S. Czer, M.H. Cohen, and S.P. Gallagher Exercise performance comparison of bicaval and biatrial orthotopic heart transplant recipients Transplant Proc 43 10 2011 3857 3862
8. A. Trento, L.S. Czer, and C. Blanche Surgical techniques for cardiac transplantation Semin Thorac Cardiovasc Surg 8 2 1996 126 132
9. A. Trento, J.M. Takkenberg, and L.S. Czer Clinical experience with one hundred consecutive patients undergoing orthotopic heart transplantation with bicaval and pulmonary venous anastomoses J Thorac Cardiovasc Surg 112 6 1996 1496 1502
10. L.V. Doering, K. Dracup, D.K. Moser, L.S. Czer, and C.T. Peter Hemodynamic adaptation to orthostatic stress after orthotopic heart transplantation Heart Lung 25 5 1996 339 351
11. L.V. Doering, K. Dracup, D.K. Moser, L.S. Czer, and C.T. Peter Evidence of time-dependent autonomic reinnervation after heart transplantation Nurs Res 48 6 1999 308 316
12. D. Freimark, L.S. Czer, and I. Aleksic Improved left atrial transport and function with orthotopic heart transplantation by bicaval and pulmonary venous anastomoses Am Heart J 130 1 1995 121 126
13. D. Freimark, J.M. Silverman, and I. Aleksic Atrial emptying with orthotopic heart transplantation using bicaval and pulmonary venous anastomoses: a magnetic resonance imaging study J Am Coll Cardiol 25 4 1995 932 936
14. S. Goland, L.S. Czer, and B. Coleman Induction therapy with thymoglobulin after heart transplantation: impact of therapy duration on lymphocyte depletion and recovery, rejection, and cytomegalovirus infection rates J Heart Lung Transplant 27 10 2008 1115 1121
15. D. Daneshvar, L.S. Czer, and A. Phan Heart transplantation in patients aged 70 years and older: a two-decade experience Transplant Proc 43 10 2011 3851 3856
16. M.E. Billingham, N.R. Cary, and M.E. Hammond A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation J Heart Transplant 9 6 1990 587 593
17. S. Stewart, G.L. Winters, and M.C. Fishbein Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection J Heart Lung Transplant 24 11 2005 1710 1720
18. J. Kobashigawa, M.G. Crespo-Leiro, and S.M. Ensminger Report from a consensus conference on antibody-mediated rejection in heart transplantation J Heart Lung Transplant 30 3 2011 252 269
19. C.D. Tan, W.M. Baldwin 3rd, and E.R. Rodriguez Update on cardiac transplantation pathology Arch Pathol Lab Med 131 8 2007 1169 1191
20. M.A. Lones, L.S. Czer, A. Trento, D. Harasty, J.M. Miller, and M.C. Fishbein Clinical-pathologic features of humoral rejection in cardiac allografts: a study in 81 consecutive patients J Heart Lung Transplant 14 1 Pt 1 1995 151 162
21. S. Goland, L.S. Czer, and R.J. Siegel Intravenous immunoglobulin treatment for acute fulminant inflammatory cardiomyopathy: series of six patients and review of literature Can J Cardiol 24 7 2008 571 574
22. S.C. Jordan, A.W. Quartel, and L.S. Czer Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action Transplantation 66 6 1998 800 805
23. S.C. Jordan, D. Tyan, L. Czer, and M. Toyoda Immunomodulatory actions of intravenous immunoglobulin (IVIG): potential applications in solid organ transplant recipients Pediatric Transplant 2 2 1998 92 105
24. L.S. Czer, A. Ruzza, and R. Vespignani Prophylaxis of cytomegalovirus disease in mismatched patients after heart transplantation using combined antiviral and immunoglobulin therapy Transplant Proc 43 5 2011 1887 1892
25. M. Toyoda, J.B. Carlos, and O.A. Galera Correlation of cytomegalovirus DNA levels with response to antiviral therapy in cardiac and renal allograft recipients Transplantaion 63 7 1997 957 963
26. J. Carlsen, M. Johansen, and S. Boesgaard Induction therapy after cardiac transplantation: a comparison of anti-thymocyte globulin and daclizumab in the prevention of acute rejection J Heart Lung Transplant 24 3 2005 296 302
27. B. Schnetzler, P. Leger, A. Volp, R. Dorent, A. Pavie, and I. Gandjbakhch A prospective randomized controlled study on the efficacy and tolerance of two antilymphocytic globulins in the prevention of rejection in first-heart transplant recipients Transplant Int 15 6 2002 317 325
28. N. Bonaros, D. Dunkler, and A. Kocher Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation J Heart Lung Transplant 25 9 2006 1154 1163
29. M. Carrier, M. Jenicek, and L.C. Pelletier Value of monoclonal antibody OKT3 in solid organ transplantation: a meta-analysis Transplant Proc 24 6 1992 2586 2591
30. N.C. Chien, F.L. Lin, and N.K. Chou Rabbit antithymocyte globulin induction immunosuppression in heart transplantation Transplant Proc 32 7 2000 2380 2382
31. R. Higgins, J.K. Kirklin, and R.N. Brown To induce or not to induce: do patients at greatest risk for fatal rejection benefit from cytolytic induction therapy? J Heart Lung Transplant 24 4 2005 392 400
32. A. Emin, C.A. Rogers, J. Thekkudan, R.S. Bonser, and N.R. Banner Steering Group UKCTA. Antithymocyte globulin induction therapy for adult heart transplantation: a UK national study J Heart Lung Transplant 30 7 2011 770 777
33. T. Yagdi, L. Sharples, S. Tsui, S. Large, and J. Parameshwar Malignancy after heart transplantation: analysis of 24-year experience at a single center J Cardiac Surg 24 5 2009 572 579
34. L.J. Swinnen, M.R. Costanzo-Nordin, and S.G. Fisher Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients N Engl J Med 323 25 1990 1723 1728